APA (7th ed.) Citation

Abraham, J. E., O’Connor, L. O., Grybowicz, L., Alba, K. P., Dayimu, A., Demiris, N., . . . Group, P. T. (2025, May). Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trial. Nature Communications.

Chicago Style (17th ed.) Citation

Abraham, Jean E., et al. "Neoadjuvant PARP Inhibitor Scheduling in BRCA1 and BRCA2 Related Breast Cancer: PARTNER, a Randomized Phase II/III Trial." Nature Communications May. 2025.

MLA (9th ed.) Citation

Abraham, Jean E., et al. "Neoadjuvant PARP Inhibitor Scheduling in BRCA1 and BRCA2 Related Breast Cancer: PARTNER, a Randomized Phase II/III Trial." Nature Communications, May. 2025.